Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients

doi:10.4251/wjgo.v14.i7.1295

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4405)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

144

WORD

HTML

1428

Figures (1-3)

266

Tables (1-5)

223

Sum=2133

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

240

Download

708

Sum=948

Publishing Process of This Article

Item

Count

Browse

326

Download

998

Sum=1324

Jul 15, 2022 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1295-1306
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1295

Table 5 Multivariate analyses of risk factors affecting overall survival in the TNM stage I + II subgroup, n = 73

Characteristics		HR (95%CI)	P value
Sex	Female	1	0.047
	Male	0.43 (0.19-0.99)
5-hmC	Low	1	0.011
	High	0.32 (0.13-0.77)

5-hmC: 5-hydroxymethylcytosine; CI: Confidence interval; HR: Hazard ratio.

Citation: Fu YL, Wu YH, Cao DH, Jia ZF, Shen A, Jiang J, Cao XY. Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients. World J Gastrointest Oncol 2022; 14(7): 1295-1306
URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1295.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1295